The largest category of enriched pathways was metabolism, followed by immune-related signaling and growth factor signaling, suggesting that these cellular processes may be key for the process of metastasis in the ER+/HER2-enriched breast cancer subtype (Fig. 4l). This evidence concerns the gene ERBB2 and breast carcinoma.